MIRA
INFORM REPORT
|
Report Date : |
01.10.2013 |
IDENTIFICATION DETAILS
|
Name : |
RZ-MEDIZINTECHNIK GMBH |
|
|
|
|
Registered Office : |
Unter Haaylen 20 Tuttlingen, 78532 |
|
|
|
|
Country : |
Germany |
|
|
|
|
Financials (as on) : |
31.12.2012 |
|
|
|
|
Date of Incorporation : |
1994 |
|
|
|
|
Com. Reg. No.: |
HRB450831 |
|
|
|
|
Legal Form : |
Private Independent |
|
|
|
|
Line of Business : |
Manufacture of instruments and appliances used for medical, surgical, dental or veterinary purposes |
|
|
|
|
No. of Employees : |
19 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
Payment Behaviour : |
Unknown |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2013
|
Country Name |
Previous Rating (31.12.2012) |
Current Rating (31.03.2013) |
|
Germany |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
GERMANY - ECONOMIC OVERVIEW
The German economy - the fifth largest economy in the world
in PPP terms and Europe's largest - is a leading exporter of machinery,
vehicles, chemicals, and household equipment and benefits from a highly skilled
labor force. Like its Western European neighbors, Germany faces significant
demographic challenges to sustained long-term growth. Low fertility rates and
declining net immigration are increasing pressure on the country's social
welfare system and necessitate structural reforms. Reforms launched by the
government of Chancellor Gerhard SCHROEDER (1998-2005), deemed necessary to
address chronically high unemployment and low average growth, contributed to
strong growth in 2006 and 2007 and falling unemployment. These advances, as
well as a government subsidized, reduced working hour scheme, help explain the
relatively modest increase in unemployment during the 2008-09 recession - the
deepest since World War II - and its decrease to 6.5% in 2012. GDP contracted
5.1% in 2009 but grew by 4.2% in 2010, and 3.0% in 2011, before dipping to 0.7%
in 2012 - a reflection of low investment spending due to crisis-induced
uncertainty and the decreased demand for German exports from recession-stricken
periphery countries. Stimulus and stabilization efforts initiated in 2008 and
2009 and tax cuts introduced in Chancellor Angela MERKEL's second term
increased Germany's total budget deficit - including federal, state, and
municipal - to 4.1% in 2010, but slower spending and higher tax revenues
reduced the deficit to 0.8% in 2011. In 2012 Germany reached a budget surplus of
0.1%. A constitutional amendment approved in 2009 limits the federal government
to structural deficits of no more than 0.35% of GDP per annum as of 2016 though
the target was already reached in 2012. By 2014, the federal government wants
to balance its budget. Following the March 2011 Fukushima nuclear disaster,
Chancellor Angela Merkel announced in May 2011 that eight of the country's 17
nuclear reactors would be shut down immediately and the remaining plants would
close by 2022. Germany hopes to replace nuclear power with renewable energy.
Before the shutdown of the eight reactors, Germany relied on nuclear power for
23% of its electricity generating capacity and 46% of its base-load electricity
production
Source
: CIA
Company name and address
|
RZ-Medizintechnik GmbH |
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Business Description
|
RZ-Medizintechnik GmbH is primarily engaged in manufacture of instruments and appliances used for medical, surgical, dental or veterinary purposes (electro-diagnostic apparatus such as electrocardiographs, ultrasonic diagnostic equipment, scintillation scanners, nuclear magnetic resonance apparatus, dental drill engines, sterilizers, ophthalmic instruments); manufacture of syringes, needles used in medicine, mirrors, reflectors, endoscopes, etc.; manufacture of apparatus based on the use of X-rays or alpha, beta or gamma radiation whether ornot for use in human or animal medicine (X-ray tubes, high tension generators, control panels, desks, screens, etc.); manufacture of medical, surgical, dental or veterinary furniture (operating tables, hospital beds with mechanical fittings, dentists’ chairs); and manufacture of mechano-therapy appliances, massage apparatus, psychological testing apparatus, ozone therapy, oxygen therapy, artificial respiration apparatus, gas masks, etc. This class also includes: manufacture of orthopaedic appliances (crutches, surgical belts and trusses, splints, artificial teeth, artificial limbs and other artificial parts of the body, hearing aids, pace-makers, orthopaedic shoes, etc.). |
Industry
|
Industry |
|
|
ANZSIC 2006: |
|
|
ISIC Rev 4: |
3250 - Manufacture of medical and dental instruments and supplies |
|
NACE Rev 2: |
3250 - Manufacture of medical and dental instruments and supplies |
|
NAICS 2012: |
|
|
UK SIC 2007: |
3250 - Manufacture of medical and dental instruments and supplies |
|
US SIC 1987: |
Key Executives
|
Registered No.(Other): HRB450831
Parent Registered No.(UK): DEU
1 - Profit & Loss Item Exchange Rate: USD 1 = EUR
0.7782366
2 - Balance Sheet Item Exchange Rate: USD 1 = EUR 0.7566
Corporate Overview
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Executives
Report
|
Annual Profit & Loss
|
|
31-Dec-2012 |
31-Dec-2011 |
31-Dec-2010 |
|
Period Length |
12 Months |
12 Months |
12 Months |
|
Filed Currency |
EUR |
EUR |
EUR |
|
Exchange Rate (Period Average) |
0.778237 |
0.71919 |
0.755078 |
|
Consolidated |
No |
No |
No |
|
|
|
|
|
|
Provisions |
0.0 |
0.1 |
0.0 |
|
|
|
Annual Balance Sheet |
|
Financials in: USD (mil) |
|
|
31-Dec-2012 |
31-Dec-2011 |
31-Dec-2010 |
|
Filed Currency |
EUR |
EUR |
EUR |
|
Exchange Rate |
0.7566 |
0.770327 |
0.745406 |
|
Consolidated |
No |
No |
No |
|
|
|
|
|
|
Issued capital |
0.0 |
0.0 |
0.0 |
|
Capital reserves |
0.0 |
0.0 |
0.0 |
|
Profits for the year |
1.4 |
0.9 |
0.5 |
|
Total stockholders equity |
1.5 |
1.0 |
0.6 |
|
Provisions and allowances |
0.0 |
0.1 |
0.0 |
|
Total long-term liabilities |
0.4 |
0.5 |
0.4 |
|
Total current liabilities |
1.1 |
0.5 |
0.9 |
|
Total liabilities (including net worth) |
3.0 |
2.2 |
1.8 |
|
Intangibles |
0.0 |
0.0 |
0.0 |
|
Total tangible fixed assets |
0.1 |
0.1 |
0.1 |
|
Total financial assets |
0.0 |
0.0 |
0.0 |
|
Total non-current assets |
0.1 |
0.1 |
0.2 |
|
Net stocks and work in progress |
0.9 |
0.7 |
0.6 |
|
Total receivables |
2.0 |
1.3 |
1.0 |
|
Cash and liquid assets |
0.0 |
0.0 |
0.0 |
|
Total current assets |
2.9 |
2.0 |
1.7 |
|
Prepaid expenses and deferred costs |
0.0 |
0.0 |
0.0 |
|
Total assets |
3.0 |
2.2 |
1.8 |
|
|
|
Annual Ratios |
|
Financials in: USD (mil) |
|
|
31-Dec-2012 |
31-Dec-2011 |
31-Dec-2010 |
|
Period Length |
12 Months |
12 Months |
12 Months |
|
Filed Currency |
EUR |
EUR |
EUR |
|
Exchange Rate |
0.7566 |
0.770327 |
0.745406 |
|
Consolidated |
No |
No |
No |
|
|
|
|
|
|
Current ratio |
26.41 |
37.76 |
19.19 |
|
Acid test ratio |
18.25 |
24.15 |
12.01 |
|
Total liabilities to net worth |
0.10% |
0.11% |
0.22% |
|
Net worth to total assets |
0.05% |
0.04% |
0.03% |
|
Current liabilities to net worth |
0.07% |
0.06% |
0.15% |
|
Current liabilities to stock |
0.12% |
0.07% |
0.14% |
|
Fixed assets to net worth |
0.01% |
0.02% |
0.03% |
|
Net worth |
1.5 |
1.0 |
0.6 |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.62.78 |
|
|
1 |
Rs.101.42 |
|
Euro |
1 |
Rs.84.67 |
INFORMATION DETAILS
|
Report
Prepared by : |
NIS |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.